Sarcoma

Clinical Guidelines and Practice Parameters

National Comprehensive Cancer Network

European Society for Medical Oncology

Predictive Models and Nomograms

Memorial Sloan Kettering Cancer Center

Phase III Clinical Trials

Clinical trials.gov lists 40 phase III trials

Upcoming Meetings

Society for Surgical Oncology

ASCO Annual Meeting

Connective Tissue Oncology Society

Reliable Resources

National Cancer Institute

American Cancer Society

Recent High-Impact Articles

Comparison of Perioperative Radiation Therapy and Surgery Versus Surgery Alone in 204 Patients With Primary Retroperitoneal Sarcoma: A Retrospective 2-Institution Study. » July 2015

Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial. » May 2015

Histology-Based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma. » April 2015

Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study. » April 2015

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial. » April 2015

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial. » March 2015

Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial. » February 2015